Literature DB >> 8152806

The t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome.

J M Shipley1, J Clark, A J Crew, S Birdsall, P J Rocques, S Gill, J Chelly, A P Monaco, S Abe, B A Gusterson.   

Abstract

A high proportion of synovial sarcomas contain the reciprocal translocation t(X;18)(p11.2;q11.2). We have previously localized the breakpoint on the X chromosome between the X chromosome marker DXS255 and an ornithine aminotransferase (OAT) pseudogene region designated OATL2. Subsequently by fluorescence in situ hybridization (FISH) we provided evidence that YACs corresponding to the OATL2 locus spanned the break-point. In order to confirm the position of this breakpoint cosmids corresponding to the OATL2 region were isolated. Most of these cosmids mapped to four cosmid contigs designated C1-C4. Analysis of two contigs, C1- and C4, using FISH established that in four of six synovial sarcomas examined the breakpoint occurs between these two contigs: C1 lies distal to the break-point while C4 is proximal. In contrast we provide evidence that the breakpoint in the remaining two tumours mapped to a second pseudogene region called OATL1 that is telomeric to the OATL2 locus. This heterogeneity of the breakpoint position on the X chromosome explains why in previous mapping studies there have been discrepancies between the results obtained by different laboratories.

Entities:  

Mesh:

Year:  1994        PMID: 8152806

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

Review 1.  Illuminating the functional and structural repertoire of human TBC/RABGAPs.

Authors:  Marieke A M Frasa; Katja T Koessmeier; M Reza Ahmadian; Vania M M Braga
Journal:  Nat Rev Mol Cell Biol       Date:  2012-01-18       Impact factor: 94.444

2.  A case report of synovial sarcoma with translocation (X;18). Application of fluorescence in situ hybridization to paraffin-embedded tissue.

Authors:  K Nagao; Y Gomyo; H Ito; K Yamamoto; H Yoshida
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma.

Authors:  J Shipley; J Crew; S Birdsall; S Gill; J Clark; C Fisher; A Kelsey; T Nojima; H Sonobe; C Cooper; B Gusterson
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

Review 4.  Synovial sarcoma: from genetics to genetic-based animal modeling.

Authors:  Malay Haldar; R Lor Randall; Mario R Capecchi
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

Review 5.  The SSX family of cancer-testis antigens as target proteins for tumor therapy.

Authors:  Heath A Smith; Douglas G McNeel
Journal:  Clin Dev Immunol       Date:  2010-10-11

6.  Expression profile of microRNAs in c-Myc induced mouse mammary tumors.

Authors:  Yuan Sun; Jack Wu; Si-hung Wu; Archana Thakur; Aliccia Bollig; Yong Huang; D Joshua Liao
Journal:  Breast Cancer Res Treat       Date:  2008-09-07       Impact factor: 4.872

7.  Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript.

Authors:  I Fligman; F Lonardo; S C Jhanwar; W L Gerald; J Woodruff; M Ladanyi
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

Review 8.  Ornithine Aminotransferase, an Important Glutamate-Metabolizing Enzyme at the Crossroads of Multiple Metabolic Pathways.

Authors:  Antonin Ginguay; Luc Cynober; Emmanuel Curis; Ioannis Nicolis
Journal:  Biology (Basel)       Date:  2017-03-07

Review 9.  Epigenetic Targets in Synovial Sarcoma: A Mini-Review.

Authors:  Ryland Hale; Sami Sandakly; Janet Shipley; Zoë Walters
Journal:  Front Oncol       Date:  2019-10-18       Impact factor: 6.244

10.  Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma.

Authors:  A J Crew; J Clark; C Fisher; S Gill; R Grimer; A Chand; J Shipley; B A Gusterson; C S Cooper
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.